Status:
COMPLETED
Clinical and Radiomic Model of COVID-19
Lead Sponsor:
Maastricht University
Collaborating Sponsors:
Wuhan Central Hospital
Conditions:
Coronavirus
Machine Learning
Eligibility:
All Genders
Brief Summary
To develop and validate a machine-learning model based on clinical, laboratory, and radiological characteristics alone or combination of COVID-19 patients to facilitate risk Assessment before and afte...
Detailed Description
In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; earlier named as 2019-nCoV), emerged in Wuhan, China. The diseases caused by SARS-CoV-2 is COVID-19....
Eligibility Criteria
Inclusion
- confirmed COVID-19 patients by high-throughput sequencing or real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay for nasal and pharyngeal swab specimens.
Exclusion
- patients with severe illness when admitted;
- time interval \> 2 days between the admission and examinations;
- absent data or delayed results
Key Trial Info
Start Date :
December 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 3 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04337502
Start Date
December 23 2019
End Date
March 3 2020
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The central hospital of Wuhan
Wuhan, Hubei, China